Analysis of how GP-led secondaries and continuation funds are reshaping private equity and venture capital, with data, regulatory context, and an LP playbook for pricing, conflicts, and governance.

When GP-led secondaries rival IPOs, the pricing game changes

GP-led secondary transactions start to pull against limited partner incentives the moment these deals rival IPO and M&A outcomes in aggregate value. Over the last rolling twelve months to Q1 2024, the volume of GP-led secondary transactions and continuation vehicles in the private equity and venture asset class has approached the combined value of traditional exits, which shifts how every fund partner must think about performance, liquidity, and carried interest. When the secondary market becomes a parallel exit lane rather than a niche liquidity tool, the sign that power has moved from public markets to fund managers is unmistakable.

For a venture fund running a GP-led secondary, the core tension is simple but brutal. You are simultaneously the seller of assets from the existing fund, the buyer through a continuation vehicle, and the architect of the secondary transaction terms that will bind both existing LPs and new investors. That triple role creates structural potential conflicts of interest around valuation, asset selection, and fee and carry resets that no side letter can fully sanitize.

On pricing, GP-led secondary deal terms often diverge from LP expectations because the GP controls the information flow on portfolio assets and frequently sets the reference valuation. In a led secondary process, the GP curates which asset or bundle of assets moves into a continuation fund, then invites secondary investors to anchor the transaction at a negotiated discount or premium to the last round or to a third party valuation. As discounts in high quality continuation funds have narrowed from double digits to low single digits in the 2022–2024 market, the signal is clear: investors now treat these continuation vehicles as core investment opportunities, not distressed selling LPs situations.

For existing LPs in the original fund, the menu looks deceptively simple. They can sell into the secondary market at the agreed price, roll their interest into the continuation vehicle on the new terms, or occasionally split their position across both options. In practice, each choice embeds a different view on the GP’s ability to compound equity value in late stage assets, the fairness of the secondary transaction pricing, and the durability of the broader market cycle.

As secondaries scale, vintage year performance becomes harder to interpret. A strong continuation transaction can crystallize performance in the original fund while shifting future upside into a new vehicle, which flatters DPI in the legacy structure but obscures how much value creation is still ahead. For LPs benchmarking managers across funds and asset classes, GP-led portfolio transfers complicate LP level attribution because the same underlying assets may drive multiple performance stories over time.

Regulators have started to notice that GP-led secondary structures can undermine LP protections when disclosure is thin and governance is weak. Heightened regulatory scrutiny in the United States and Europe now focuses on how conflicts of interest are managed when GPs run led transactions that move assets between affiliated funds. As guidance from agencies that combat fraud in financial markets evolves, illustrated by SEC enforcement actions such as the 2022 case against a large private equity adviser for inadequate disclosure of GP-led restructuring conflicts, LPs should expect more emphasis on independent fairness opinions, transparent fee structures, and explicit consent processes for selling LPs in these secondary transactions.

Where the conflicts bite hardest for LPs

The most acute misalignment between GP-led secondary pricing and LP interests appears at three choke points: asset selection, valuation, and economics. First, the GP chooses which portfolio companies or other assets leave the existing fund and enter the continuation vehicle, which can create subtle but powerful incentives to cherry pick winners or offload problem positions. Second, the GP often negotiates directly with new secondary investors on price, then presents that valuation to existing LPs as a take it or roll decision.

Asset selection is rarely neutral in a continuation fund. A GP with a concentrated winner may want to reset carried interest on that single asset by moving it into a continuation vehicle, while leaving weaker assets behind in the existing fund where carry is already out of the money. Conversely, a GP under pressure might be tempted to package mixed quality assets into continuation funds to generate liquidity and management fee longevity, which again shows how GP-led secondaries can diverge from LP preferences for clean, high conviction exposure.

Valuation is the second fault line. In a led secondary, the GP typically runs a process with a small group of secondary investors, who may be long standing relationships across multiple funds and transactions. When that tight circle sets the price for a secondary transaction, existing LPs must decide whether the valuation fairly reflects the private equity market for comparable assets or whether relationship dynamics and future fundraising prospects have influenced the outcome.

Regulatory scrutiny increasingly focuses on this valuation dynamic. Supervisors have made clear through enforcement actions and guidance that conflicts of interest must be explicitly identified and mitigated when GPs orchestrate led secondaries that move assets between affiliated vehicles. For LPs, one practical step is to insist on a truly independent third party fairness opinion that assesses the valuation of the asset or assets being transferred, rather than relying solely on the GP and the lead investor.

Economics form the third pressure point where GP-led secondary deal design can reshape LP outcomes. In many continuation vehicles, the GP resets carried interest and sometimes management fees on the transferred assets, effectively re underwriting upside that was already in the money for existing LPs. When selling LPs accept liquidity at a negotiated price, they may be leaving significant future equity value on the table while the GP and new investors capture a fresh layer of carry on the same underlying assets.

LPs should also pay close attention to stapled commitments and cross fund dynamics. A continuation transaction that requires new commitments to a future fund as a condition of access to the continuation vehicle can entrench GP power and blur the line between secondary market pricing and primary fundraising. For a deeper view on how regulators such as the SEC and CFTC frame these issues in the context of fraud and market integrity, senior investors should study analyses of how the SEC and CFTC combat fraud in financial markets, then map that lens onto GP-led secondaries and continuation funds.

The LP playbook for underwriting GP-led secondaries

LPs need a disciplined framework because GP-led secondary structures can run against LP instincts to trust long standing managers. Start with process: was there a broad auction with multiple secondary investors, or a narrow bilateral negotiation that concentrated information and leverage. A genuinely competitive process in the secondary market is the cleanest sign that the transaction price approximates fair value for the asset class and the specific assets in play.

Next, interrogate the continuation vehicle structure. A robust continuation fund should offer existing LPs a clear choice between selling and rolling, with no coercive features such as punitive terms for those who decline to participate. The continuation vehicle should also align economics by offering rolled interest parity with new investors where feasible, or at least transparent disclosure of any differences in fees, carried interest, or governance rights.

Independent valuation is non negotiable when GP-led secondary pricing tests LP confidence in the numbers. LPs should require a third party valuation firm to opine on the fairness of the transaction price, using market based comparables, recent primary transactions, and scenario analysis on exit outcomes. That fairness opinion should be shared in full with all existing LPs in the existing fund, not summarized selectively.

Governance is the second pillar of the LP playbook. A best practice continuation transaction uses an LP advisory committee or a special conflicts committee composed of disinterested investors to review the process, the valuation, and the economic terms. Those committees should have real veto power over the led secondary, not just an advisory role, especially when potential conflicts are acute or when the GP is resetting carry on a concentrated asset.

Legal and regulatory terms matter as much as price. LPs should ensure that disclosure documents clearly describe all conflicts of interest, including any stapled commitments, cross fund guarantees, or side letters with anchor investors in the continuation vehicle. For GPs, this is where a carefully crafted investment agreement can either build trust or erode it, and senior leaders should benchmark their documentation against guides for crafting a comprehensive investment agreement that align interests across funds, investors, and transactions.

Finally, LPs should re underwrite the underlying companies or assets, not just the structure. A continuation fund that holds late stage venture assets with credible paths to liquidity in three to five years is very different from a vehicle that warehouses aging positions with uncertain exit prospects. The more GP-led secondary deal design stretches LP appetite for duration and risk, the more granular the underwriting must become, down to company level unit economics, governance, and capital structure.

How secondaries reshape performance, power, and strategy

As GP-led secondary activity reshapes expectations about vintage performance, the industry’s mental models need to catch up. When a GP moves a star asset into a continuation vehicle, the original fund books a realized gain while the new vehicle carries the equity at a fresh valuation, which can inflate apparent DPI without fully reflecting remaining risk. For LPs comparing funds across managers and asset classes, this double counting of value creation across multiple funds and continuation vehicles can distort manager selection.

Power dynamics also shift when secondaries rival IPOs and M&A in scale. GPs who can reliably run led secondaries and continuation funds gain a new strategic option for managing portfolio duration, fundraising cycles, and team economics. That optionality can be healthy when used to extend the runway for exceptional assets, but it can also entrench managers whose performance would otherwise be constrained by the natural life of an existing fund.

For venture GPs, the strategic question is whether to treat GP-led secondaries as a core tool or an emergency valve. Used thoughtfully, a led secondary can align investors by offering liquidity to selling LPs while giving long term backers and new investors a chance to double down on high conviction assets. Used reflexively, it can mask portfolio construction mistakes, delay hard decisions on underperforming assets, and create layers of carried interest that test LP tolerance for complexity.

LPs should respond by upgrading their own playbooks. That means tracking GP behavior across multiple funds and continuation transactions, noting patterns in when and how continuation funds are used, and assessing whether regulatory scrutiny or market feedback has changed the GP’s approach over time. It also means building internal expertise on secondary market dynamics, rather than outsourcing all judgment to external advisers or lead investors.

Fund managers, especially in venture, must integrate secondaries strategy into their overall capital formation plan. The choice of fund size, check size, and portfolio concentration now interacts directly with the feasibility of future continuation vehicles, as shown in analyses of how fund size shapes strategic options for chief executives and investors. When GP-led secondary activity diverges from LP expectations about how and when liquidity will arrive, the root cause often lies in misaligned fund design rather than in any single transaction.

In the end, secondaries are not just another transaction type. They are a governance technology that reallocates time, risk, and power between GPs, LPs, and portfolio companies, and the real story is not the term sheet but the power it encodes. As GP-led secondaries and continuation funds continue to scale, the investors who master this technology will quietly rewrite the rules of private equity and venture performance, as illustrated by high profile continuation deals such as the 2020–2021 restructuring of flagship buyout funds that moved marquee assets into multi billion dollar vehicles.

Key figures on GP-led secondaries and continuation vehicles

  • Global private equity secondary market volume exceeded 100 billion dollars in 2023, with GP-led secondaries and continuation funds representing roughly half of total transactions according to data from leading secondary advisers, which marks a structural shift from LP portfolio sales to GP-driven deals.
  • Industry analyses from firms such as HarbourVest Partners and Global Corporate Venturing indicate that over the twelve month period ending Q4 2023, the combined value of GP-led secondary transactions and continuation vehicles in private markets approached the aggregate value of IPO and M&A exits for venture backed and buyout backed companies, underscoring how secondaries now function as a parallel exit channel.
  • Discounts on high quality GP-led continuation funds have compressed from historical levels in the mid teens to low single digit percentages in recent market conditions, reflecting strong investor demand for concentrated exposure to top assets and increasing comfort with the GP-led structure.
  • Regulatory filings and enforcement actions in the United States, including SEC cases announced between 2020 and 2023 that focused on disclosure failures in GP-led restructurings, show a rising number of matters centered on conflicts of interest and valuation in private fund secondary transactions, signaling that GP-led secondary practices and LP protections will remain a priority area for supervisors.
  • Surveys of institutional investors by major consultants report that a growing share of LPs, often more than one third of respondents as of 2023, now have dedicated allocation buckets or explicit policies for evaluating continuation vehicles and GP-led secondaries, which formalizes the role of these structures in portfolio construction.
Published on